Loomis, Sayles & Company
COV

Loomis, Sayles & Company’s COVIDIEN PLC COM SHS NEW (IRELAND) COV Stock Holding History

Loomis, Sayles & Company’s Portfolio COV Stock Details COV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-744,398
Closed -$76.1M – 795
2014
Q4 		$76.1M Sell
744,398
-119,088
-14% -$11.4M 0.21% 93
2014
Q3 		$74.7M Sell
863,486
-289,700
-25% -$25.7M 0.22% 94
2014
Q2 		$104M Sell
1,153,186
-397,460
-26% -$29.7M 0.3% 72
2014
Q1 		$114M Buy
1,550,646
+338,257
+28% +$23.6M 0.32% 71
2013
Q4 		$82.6M Buy
1,212,389
+58,838
+5% +$3.83M 0.25% 104
2013
Q3 		$70.3M Sell
1,153,551
-131,036
-10% -$8M 0.23% 113
2013
Q2 		$71.6K Buy
+1,284,587
New +$74.3M 0.26% 91

Loomis, Sayles & Company's COV Position: Q1 2015 in Review

Loomis, Sayles & Company sold out of COVIDIEN PLC COM SHS NEW (IRELAND) (COV) in Q1 2015, closing a stake of 744,398 shares — an estimated $76.1M sold.

Loomis, Sayles & Company first reported a position in COV in Q2 2013 and held it in 7 quarters. The position peaked at $114M in Q1 2014. 1 fund tracked by Wall St. Rank holds COV as of Q1 2015.

  • Loomis, Sayles & Company reported no remaining COVIDIEN PLC COM SHS NEW (IRELAND) position as of Q1 2015 after selling out during the quarter.
  • Loomis, Sayles & Company sold 744,398 COVIDIEN PLC COM SHS NEW (IRELAND) shares in Q1 2015, an estimated $76.1M.
  • Loomis, Sayles & Company first reported a position in COVIDIEN PLC COM SHS NEW (IRELAND) in Q2 2013 and held it in 7 quarters.
  • Loomis, Sayles & Company's COVIDIEN PLC COM SHS NEW (IRELAND) position peaked at $114M in Q1 2014.
  • 1 fund tracked by Wall St. Rank held COVIDIEN PLC COM SHS NEW (IRELAND) as of Q1 2015.

Based on Loomis, Sayles & Company's 13F filing for Q1 2015, filed 14 May 2015.